Requiring coverage of home blood pressure monitoring devices for certain Medicaid recipients
Summary
SB252 amends West Virginia Code §9-5-20 to expand Medicaid-related coverage and reimbursement for blood pressure monitoring and kidney disease screening services. The bill requires Medicaid to cover evaluation for chronic kidney disease for enrollees with diabetes, hypertension, or a family history of kidney disease, and it classifies certain enrollees diagnosed with kidney disease as chronic kidney patients. It also directs the Bureau for Public Health to educate Medicaid providers on chronic kidney disease management, including risk-factor control, bone and cardiovascular disease, nutrition, and anemia.
The bill’s central change is to require Medicaid coverage for a self-measured, validated home blood pressure monitoring device for pregnant enrollees and those within 12 months postpartum who have uncontrolled hypertension. It further requires the Bureau of Medical Services to draft a State Plan Amendment to add coverage for home blood pressure monitoring, including an extra cuff, reimbursement for the device, and payment for related services such as patient training, interpretation of readings, and co-interventions.
Impact
If enacted, SB252 would expand Medicaid benefits and administrative obligations in West Virginia by adding coverage requirements for home blood pressure monitoring devices and related services, while also reinforcing existing kidney disease screening and provider-education provisions. It would affect Medicaid enrollees with hypertension, especially pregnant and postpartum patients, as well as providers and the Bureau of Medical Services, which would need to implement a State Plan Amendment and establish reimbursement for the new covered items and services.
Sentiment
The available voting history suggests the bill was generally supported in the Senate, passing 26-6 on April 2, 2025. No committee transcript is available, but the vote margin indicates broad, though not unanimous, approval for expanding Medicaid coverage related to hypertension monitoring and chronic kidney disease prevention.
Contention
The main points of potential contention are the cost and scope of expanding Medicaid coverage, including reimbursement for devices, extra cuffs, training, interpretation of readings, and other co-interventions. Opponents may also have concerns about adding new state-plan obligations and administrative complexity, while supporters likely view the bill as a preventive health measure aimed at improving blood pressure control and reducing complications for high-risk Medicaid enrollees, particularly pregnant and postpartum patients.